Company Filing History:
Years Active: 2018-2022
Title: Sandrine Romand: Innovator in Recombinant Protein Production
Introduction
Sandrine Romand is a prominent inventor based in Seyssinet-Pariset, France. She has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein production. With a total of 2 patents, her work has advanced the methods used to produce therapeutic proteins in mammalian cells.
Latest Patents
One of her latest patents is titled "Vertebrate cells and methods for recombinantly expressing a polypeptide of interest." This invention focuses on isolated vertebrate cells that are modified to impair the function of the endogenous protease matriptase. The cells are designed to express a polypeptide of interest, which is secreted into the cell culture medium, significantly reducing the clipping of the polypeptide. This innovation provides improved production and screening methods for recombinant proteins.
Another notable patent is "Production of therapeutic proteins in genetically modified mammalian cells." This invention outlines methods for producing therapeutic proteins, such as IGF-1, in mammalian cells that are deficient in the expression of the cognate receptor. The method allows for a higher yield of therapeutic protein, enhancing the efficiency of protein production in biotechnological applications.
Career Highlights
Sandrine Romand is currently employed at Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to further her research and development in the field of biotechnology, contributing to innovative solutions in therapeutic protein production.
Collaborations
Throughout her career, Sandrine has collaborated with notable colleagues, including Holger Laux and Ursula Bodendorf. These collaborations have fostered a productive environment for innovation and research in her field.
Conclusion
Sandrine Romand's contributions to biotechnology, particularly in recombinant protein production, have established her as a key inventor in the industry. Her patents reflect her commitment to advancing scientific knowledge and improving therapeutic applications.